{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:41:43Z","timestamp":1771890103540,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Cancer Hospital Outstanding Youth Funding","award":["YB 2023022"],"award-info":[{"award-number":["YB 2023022"]}]},{"name":"Sichuan Cancer Hospital outstanding youth Fund","award":["YB.2021029"],"award-info":[{"award-number":["YB.2021029"]}]},{"name":"Sichuan Provincial Science and Technology Department Project","award":["No.2022YFS0068"],"award-info":[{"award-number":["No.2022YFS0068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-024-01376-4","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:02:29Z","timestamp":1722358949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comparative study of 18F-PSMA-1007 PET\/CT and pelvic MRI in newly diagnosed prostate cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhenyan","family":"Ye","sequence":"first","affiliation":[]},{"given":"Ying","family":"Kou","sequence":"additional","affiliation":[]},{"given":"Jiaqi","family":"Shen","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Dang","sequence":"additional","affiliation":[]},{"given":"Xiaofei","family":"Tan","sequence":"additional","affiliation":[]},{"given":"Xiao","family":"Jiang","sequence":"additional","affiliation":[]},{"given":"Xiaoxiong","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Shirong","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Zhuzhong","family":"Cheng","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"issue":"1","key":"1376_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1376_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.6004\/jnccn.2023.0014","volume":"21","author":"KA Moses","year":"2023","unstructured":"Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall\u2019Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. NCCN Guidelines\u00ae insights: prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023;21(3):236\u201346.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10071","key":"1376_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M. PROMIS study group. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815\u201322.","journal-title":"Lancet"},{"issue":"6","key":"1376_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.eururo.2015.01.013","volume":"68","author":"JJ F\u00fctterer","year":"2015","unstructured":"F\u00fctterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, Taneja SS, Thoeny H, Villeirs G, Villers A. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68(6):1045\u201353.","journal-title":"Eur Urol"},{"issue":"11","key":"1376_CR5","first-page":"1624","volume":"58","author":"FP Calace","year":"2022","unstructured":"Calace FP, Napolitano L, Arcaniolo D, Stizzo M, Barone B, Crocetto F, Olivetta M, Amicuzi U, Cirillo L, Rubinacci A, Lecce A, Pandolfo SD, Langella NA, Persico F, Trama F, Quattrone C, Bottone F, Spirito L, De Sio M, Manfredi C. Micro-ultrasound in the diagnosis and staging of prostate and bladder cancer: a comprehensive review. Med (Kaunas). 2022;58(11):1624.","journal-title":"Med (Kaunas)"},{"issue":"1","key":"1376_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00259-017-3818-x","volume":"45","author":"E Mena","year":"2018","unstructured":"Mena E, Lindenberg ML, Shih JH, Adler S, Harmon S, Bergvall E, Citrin D, Dahut W, Ton AT, McKinney Y, Weaver J, Eclarinal P, Forest A, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Pinto P, Wood BJ, Jacobs P, Pomper MG, Choyke PL, Turkbey B. Clinical impact of PSMA-based 18F-DCFBC PET\/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy. Eur J Nucl Med Mol Imaging. 2018;45(1):4\u201311.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1376_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bju.14856","volume":"124","author":"GJR Cook","year":"2019","unstructured":"Cook GJR, Kulkarni M, Warbey VS. PSMA PET\/CT imaging for primary staging of intermediate and high-risk prostate cancer. BJU Int. 2019;124(3):357\u20138.","journal-title":"BJU Int"},{"key":"1376_CR8","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Garz\u00f3n JR, de Arcocha Torres M, Delgado-Bolton R, Ceci F, Alvarez Ruiz S, Orcajo Rinc\u00f3n J, Caresia Ar\u00f3ztegui AP, Garc\u00eda Velloso MJ, Garc\u00eda Vicente AM. Oncology task force of Spanish society of nuclear medicine and molecular imaging. 68Ga-PSMA PET\/CT in prostate cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Mar-Apr;37(2):130\u20138.","DOI":"10.1016\/j.remnie.2017.10.016"},{"key":"1376_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2019.04.004","volume":"130","author":"MA Hoffmann","year":"2019","unstructured":"Hoffmann MA, Wieler HJ, Baues C, Kuntz NJ, Richardsen I, Schreckenberger M. The impact of 68Ga-PSMA PET\/CT and PET\/MRI on the management of prostate cancer. Urology. 2019;130:1\u201312.","journal-title":"Urology"},{"issue":"2","key":"1376_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2967\/jnumed.118.211086","volume":"60","author":"SA Koerber","year":"2019","unstructured":"Koerber SA, Will L, Kratochwil C, Haefner MF, Rathke H, Kremer C, Merkle J, Herfarth K, Kopka K, Choyke PL, Holland-Letz T, Haberkorn U, Debus J, Giesel FL. 68Ga-PSMA-11 PET\/CT in primary and recurrent prostate carcinoma: implications for radiotherapeutic management in 121 patients. J Nucl Med. 2019;60(2):234\u201340.","journal-title":"J Nucl Med"},{"issue":"3","key":"1376_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.eururo.2015.06.010","volume":"69","author":"L Bud\u00e4us","year":"2016","unstructured":"Bud\u00e4us L, Leyh-Bannurah SR, Salomon G, Michl U, Heinzer H, Huland H, Graefen M, Steuber T, Rosenbaum C. Initial experience of (68)Ga-PSMA PET\/CT imaging in high-risk prostate cancer patients prior to radical prostatectomy. Eur Urol. 2016;69(3):393\u20136.","journal-title":"Eur Urol"},{"issue":"4","key":"1376_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.juro.2016.02.3000","volume":"196","author":"H Rhee","year":"2016","unstructured":"Rhee H, Thomas P, Shepherd B, Gustafson S, Vela I, Russell PJ, Nelson C, Chung E, Wood G, Malone G, Wood S, Heathcote P. Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer. J Urol. 2016;196(4):1261\u20137.","journal-title":"J Urol"},{"key":"1376_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00259-016-3389-2","volume":"43","author":"FM Mottaghy","year":"2016","unstructured":"Mottaghy FM, Heinzel A, Verburg FA. Molecular imaging using PSMA PET\/CT versus multiparametric MRI for initial staging of prostate cancer: comparing apples with oranges? Eur J Nucl Med Mol Imaging. 2016;43:1397\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1376_CR14","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.1038\/s41598-019-46386-3","volume":"9","author":"S Mei\u00dfner","year":"2019","unstructured":"Mei\u00dfner S, Janssen JC, Prasad V, Diederichs G, Hamm B, Brenner W, Makowski MR. Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: comparison to 68Ga-PSMA PET-CT. Sci Rep. 2019;9(1):10727.","journal-title":"Sci Rep"},{"issue":"12","key":"1376_CR15","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s00259-020-04827-6","volume":"47","author":"S Spohn","year":"2020","unstructured":"Spohn S, Jaegle C, Fassbender TF, Sprave T, Gkika E, Nicolay NH, Bock M, Ruf J, Benndorf M, Gratzke C, Grosu AL, Zamboglou C. Intraindividual comparison between 68Ga-PSMA-PET\/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients. Eur J Nucl Med Mol Imaging. 2020;47(12):2796\u2013803.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"1376_CR16","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2967\/jnumed.117.190314","volume":"58","author":"SA Koerber","year":"2017","unstructured":"Koerber SA, Utzinger MT, Kratochwil C, Kesch C, Haefner MF, Katayama S, Mier W, Iagaru AH, Herfarth K, Haberkorn U, Debus J, Giesel FL. Ga-PSMA-11 PET\/CT in newly diagnosed carcinoma of the prostate: correlation of intraprostatic PSMA uptake with several clinical parameters. J Nucl Med. 2017;58(12):1943\u20138.","journal-title":"J Nucl Med"},{"issue":"6","key":"1376_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12149-020-01462-x","volume":"34","author":"C Onal","year":"2020","unstructured":"Onal C, Torun N, Oymak E, Guler OC, Reyhan M, Yapar AF. Retrospective correlation of 68ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy. Ann Nucl Med. 2020;34(6):388\u201396.","journal-title":"Ann Nucl Med"},{"issue":"3","key":"1376_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.euo.2021.02.006","volume":"5","author":"AA Kalapara","year":"2022","unstructured":"Kalapara AA, Ballok ZE, Ramdave S, O\u2019Sullivan R, Ryan A, Konety B, Grummet JP, Frydenberg M. Combined utility of Ga-prostate-specific membrane antigen positron emission tomography\/computed tomography and multiparametric magnetic resonance imaging in predicting prostate biopsy pathology. Eur Urol Oncol. 2022;5(3):314\u201320.","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"1376_CR19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","volume":"44","author":"FL Giesel","year":"2017","unstructured":"Giesel FL, Hadaschik B, Cardinale J, Radtke J, Vinsensia M, Lehnert W, Kesch C, Tolstov Y, Singer S, Grabe N, Duensing S, Sch\u00e4fer M, Neels OC, Mier W, Haberkorn U, Kopka K, Kratochwil C. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2017;44(4):678\u201388.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1376_CR20","doi-asserted-by":"crossref","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76(3):340\u201351. .","DOI":"10.1016\/j.eururo.2019.02.033"},{"issue":"6","key":"1376_CR21","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, Horninger W, Virgolini IJ. Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging. 2017;44(6):941\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1376_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41391-018-0065-6","volume":"21","author":"NJ Sathianathen","year":"2018","unstructured":"Sathianathen NJ, Konety BR, Soubra A, Metzger GJ, Spilseth B, Murugan P, Weight CJ, Ordonez MA, Warlick CA. Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications. Prostate Cancer Prostatic Dis. 2018;21(4):573\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"1376_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2017.02.021","volume":"73","author":"W Venderink","year":"2018","unstructured":"Venderink W, van Luijtelaar A, Bomers JGR, van der Leest M, Hulsbergen-van de Kaa C, Barentsz JO, Sedelaar JPM, F\u00fctterer JJ. Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer. Eur Urol. 2018;73(3):353\u201360.","journal-title":"Eur Urol"},{"issue":"1","key":"1376_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41391-018-0075-4","volume":"22","author":"NJ Sathianathen","year":"2019","unstructured":"Sathianathen NJ, Butaney M, Bongiorno C, Konety BR, Bolton DM, Lawrentschuk N. Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2019;22(1):39\u201348.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1376_CR25","doi-asserted-by":"publisher","first-page":"3794738","DOI":"10.1155\/2016\/3794738","volume":"2016","author":"F Ting","year":"2016","unstructured":"Ting F, Van Leeuwen PJ, Thompson J, Shnier R, Moses D, Delprado W, Stricker PD. Assessment of the performance of magnetic resonance imaging\/ultrasound fusion guided prostate biopsy against a combined targeted plus systematic biopsy approach using 24-core transperineal template saturation mapping prostate biopsy. Prostate Cancer. 2016;2016:3794738.","journal-title":"Prostate Cancer"},{"issue":"5","key":"1376_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/bju.13711","volume":"120","author":"NL Hansen","year":"2017","unstructured":"Hansen NL, Kesch C, Barrett T, Koo B, Radtke JP, Bonekamp D, Schlemmer HP, Warren AY, Wieczorek K, Hohenfellner M, Kastner C, Hadaschik B. Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy. BJU Int. 2017;120(5):631\u20138.","journal-title":"BJU Int"},{"issue":"2","key":"1376_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41391-018-0048-7","volume":"21","author":"I Berger","year":"2018","unstructured":"Berger I, Annabattula C, Lewis J, Shetty DV, Kam J, Maclean F, Arianayagam M, Canagasingham B, Ferguson R, Khadra M, Ko R, Winter M, Loh H, Varol C. 68Ga-PSMA PET\/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology. Prostate Cancer Prostatic Dis. 2018;21(2):204\u201311.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1376_CR28","doi-asserted-by":"crossref","unstructured":"Soni BK, Verma P, Shah AK, Singh R, Sonawane S, Asopa RV. Comparison of multiparametric magnetic resonance imaging and gallium-68 prostate-specific membrane antigen positron emission tomography\/computed tomography for detecting carcinoma prostate in patients with serum prostate-specific antigen between 4 and 20 ng\/ml. Indian J Nucl Med. 2021;36(3):245\u201351.","DOI":"10.4103\/ijnm.ijnm_243_20"},{"issue":"1","key":"1376_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.eururo.2018.03.007","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Barchetti G, Simone G, Del Monte M, Ciardi A, Grompone MD, Campa R, Indino EL, Barchetti F, Sciarra A, Leonardo C, Gallucci M, Catalano C. Negative multiparametric magnetic resonance imaging for prostate cancer: what\u2019s Next? Eur Urol. 2018;74(1):48\u201354.","journal-title":"Eur Urol"},{"issue":"7","key":"1376_CR30","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2967\/jnumed.118.221010","volume":"60","author":"M Chen","year":"2019","unstructured":"Chen M, Zhang Q, Zhang C, Zhao X, Marra G, Gao J, Lv X, Zhang B, Fu Y, Wang F, Qiu X, Guo H. Combination of Ga-PSMA PET\/CT and multiparametric MRI improves the detection of clinically significant prostate Cancer: a lesion-by-lesion analysis. J Nucl Med. 2019;60(7):944\u20139.","journal-title":"J Nucl Med"},{"key":"1376_CR31","doi-asserted-by":"crossref","unstructured":"Chandra P, Rajaian S, Krishnamurthy K, Murugasen L, Chandran G, Kumar JS, Nath S. Diagnostic accuracy of Prebiopsy Ga-68 PSMA PET\/CT in detecting primary prostate carcinomas with prostate-specific antigen\u2009<\u200950 ng\/ml. Indian J Nucl Med. 2020 Oct-Dec;35(4):283\u201390.","DOI":"10.4103\/ijnm.IJNM_81_20"},{"issue":"2","key":"1376_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00259-020-04863-2","volume":"48","author":"LL Zhang","year":"2021","unstructured":"Zhang LL, Li WC, Xu Z, Jiang N, Zang SM, Xu LW, Huang WB, Wang F, Sun HB. Ga-PSMA PET\/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study. Eur J Nucl Med Mol Imaging. 2021;48(2):483\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"1376_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.juro.2016.03.075","volume":"196","author":"M Kim","year":"2016","unstructured":"Kim M, Choi SK, Park M, Shim M, Song C, Jeong IG, Hong JH, Kim CS, Ahn H. Characteristics of anteriorly located prostate cancer and the usefulness of multiparametric magnetic resonance imaging for diagnosis. J Urol. 2016;196(2):367\u201373.","journal-title":"J Urol"},{"issue":"7","key":"1376_CR34","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2967\/jnumed.115.154336","volume":"56","author":"SP Rowe","year":"2015","unstructured":"Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, Dannals RF, Netto GJ, Lodge MA, Mease RC, Pomper MG, Cho SY. \u00b9\u2078F-DCFBC PET\/CT for PSMA-based detection and characterization of primary prostate cancer. J Nucl Med. 2015;56(7):1003\u201310.","journal-title":"J Nucl Med"},{"issue":"3","key":"1376_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/1754-9485.13284","volume":"66","author":"F Paterson","year":"2022","unstructured":"Paterson F, Nottage M, Kitchener M, Jarvis M, Reid J, Oakden-Rayner L. Assessing the accuracy of Ga-PSMA PET\/CT compared with MRI in the initial diagnosis of prostate malignancy: a cohort analysis of 114 consecutive patients. J Med Imaging Radiat Oncol. 2022;66(3):319\u201323.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"1376_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.juro.2018.01.079","volume":"200","author":"E Lopci","year":"2018","unstructured":"Lopci E, Saita A, Lazzeri M, Lughezzani G, Colombo P, Buffi NM, Hurle R, Marzo K, Peschechera R, Benetti A, Zandegiacomo S, Pasini L, Lista G, Cardone P, Castello A, Maffei D, Balzarini L, Chiti A, Guazzoni G, Casale P. Ga-PSMA positron emission tomography\/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic resonance imaging: a prospective observational study. J Urol. 2018;200(1):95\u2013103.","journal-title":"J Urol"},{"issue":"1","key":"1376_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2559.2011.04039.x","volume":"60","author":"PA Humphrey","year":"2012","unstructured":"Humphrey PA. Histological variants of prostatic carcinoma and their significance. Histopathology. 2012;60(1):59\u201374.","journal-title":"Histopathology"}],"updated-by":[{"DOI":"10.1186\/s12880-024-01412-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000}}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01376-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:52:15Z","timestamp":1726753935000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01376-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01376-4","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12880-024-01412-3","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12880-024-01412-3","URL":"https:\/\/doi.org\/10.1186\/s12880-024-01412-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance to the local regulations of China and was ethically approved by Ethics Committee of Sichuan Cancer Hospital (JS-2017\u201301\u201302). This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent has been obtained for our data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}